aluminum sulfate has been researched along with Diabetes Mellitus Type 1.5 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, A; Grill, V; Hals, IK; Ludvigsson, J | 1 |
| Balasuriya, C; Björklund, A; Casas, R; Grill, V; Hals, IK; Ludvigsson, J | 1 |
1 trial(s) available for aluminum sulfate and Diabetes Mellitus Type 1.5
| Article | Year |
|---|---|
Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.
Topics: Adult; Aged; Alum Compounds; Diabetes Mellitus, Type 1; Feasibility Studies; Glucose Intolerance; Glutamate Decarboxylase; Humans; Insulin; Latent Autoimmune Diabetes in Adults; Middle Aged; Pilot Projects; Vitamin D | 2022 |
1 other study(ies) available for aluminum sulfate and Diabetes Mellitus Type 1.5
| Article | Year |
|---|---|
A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
Topics: Adult; Autoantibodies; Diabetes Mellitus, Type 1; Glucose Intolerance; Glutamate Decarboxylase; Humans; Injections, Intralymphatic; Latent Autoimmune Diabetes in Adults; Leukocytes, Mononuclear; Middle Aged; Pilot Projects | 2023 |